Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients

Ming Fang Wu, Wen Jun Wu, Gee Chen Chang, Chin Yi Chen, Suh Woan Hu, Wen Tin Tsai, Huei Lee, Pinpin Lin

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Aryl hydrocarbon receptor (AhR)-regulated cytochrome P4501A1 (CYP1A1) and P4501B1 (CYP1B1) have been shown to metabolically activate some carcinogens. In the present study, we utilized the real-time reverse transcription-polymerase chain reaction (RT-PCR) assay to compare AhR, CYP1A1 and CYP1B1 mRNA levels in peripheral leukocytes from 42 lung cancer patients and 59 non-cancer subjects. We found that CYP1A1 and CYP1B1 levels, but not AhR, were significantly higher in patients than in non-cancer subjects. After stratified by gender, CYP1A1 levels were significantly higher in female patients than in female controls. After controlling for age, smoking status and gender, lung cancer patients were more likely to be CYP1B1 high expressers (P<0.05). Neither AhR nor CYP1A1 levels was associated with lung cancer incidence. Leu-Val polymorphism of CYP1B1 was not associated with lung cancer risk in our study. These data indicated that CYP1B1 mRNA levels were elevated in peripheral leukocytes of lung cancer patients. © 2004 Elsevier Ireland Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)211-219
Number of pages9
JournalToxicology Letters
Volume150
Issue number2
DOIs
Publication statusPublished - Apr 21 2004
Externally publishedYes

Fingerprint

Cytochrome P-450 CYP1A1
Aryl Hydrocarbon Receptors
Lung Neoplasms
Cytochromes
Leukocytes
Messenger RNA
Polymerase chain reaction
Transcription
Polymorphism
Ireland
Carcinogens
Reverse Transcription
Assays
Smoking
Cytochrome P-450 CYP1B1
Polymerase Chain Reaction
Incidence

Keywords

  • Aryl hydrocarbon receptor
  • Cytochrome P4501A1
  • Cytochrome P4501B1
  • Lung cancer

ASJC Scopus subject areas

  • Toxicology

Cite this

Wu, M. F., Wu, W. J., Chang, G. C., Chen, C. Y., Hu, S. W., Tsai, W. T., ... Lin, P. (2004). Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients. Toxicology Letters, 150(2), 211-219. https://doi.org/10.1016/j.toxlet.2004.01.006

Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients. / Wu, Ming Fang; Wu, Wen Jun; Chang, Gee Chen; Chen, Chin Yi; Hu, Suh Woan; Tsai, Wen Tin; Lee, Huei; Lin, Pinpin.

In: Toxicology Letters, Vol. 150, No. 2, 21.04.2004, p. 211-219.

Research output: Contribution to journalArticle

Wu, MF, Wu, WJ, Chang, GC, Chen, CY, Hu, SW, Tsai, WT, Lee, H & Lin, P 2004, 'Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients', Toxicology Letters, vol. 150, no. 2, pp. 211-219. https://doi.org/10.1016/j.toxlet.2004.01.006
Wu, Ming Fang ; Wu, Wen Jun ; Chang, Gee Chen ; Chen, Chin Yi ; Hu, Suh Woan ; Tsai, Wen Tin ; Lee, Huei ; Lin, Pinpin. / Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients. In: Toxicology Letters. 2004 ; Vol. 150, No. 2. pp. 211-219.
@article{b69cfbc3b8524043b13c7644cb3feaa9,
title = "Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients",
abstract = "Aryl hydrocarbon receptor (AhR)-regulated cytochrome P4501A1 (CYP1A1) and P4501B1 (CYP1B1) have been shown to metabolically activate some carcinogens. In the present study, we utilized the real-time reverse transcription-polymerase chain reaction (RT-PCR) assay to compare AhR, CYP1A1 and CYP1B1 mRNA levels in peripheral leukocytes from 42 lung cancer patients and 59 non-cancer subjects. We found that CYP1A1 and CYP1B1 levels, but not AhR, were significantly higher in patients than in non-cancer subjects. After stratified by gender, CYP1A1 levels were significantly higher in female patients than in female controls. After controlling for age, smoking status and gender, lung cancer patients were more likely to be CYP1B1 high expressers (P<0.05). Neither AhR nor CYP1A1 levels was associated with lung cancer incidence. Leu-Val polymorphism of CYP1B1 was not associated with lung cancer risk in our study. These data indicated that CYP1B1 mRNA levels were elevated in peripheral leukocytes of lung cancer patients. {\circledC} 2004 Elsevier Ireland Ltd. All rights reserved.",
keywords = "Aryl hydrocarbon receptor, Cytochrome P4501A1, Cytochrome P4501B1, Lung cancer",
author = "Wu, {Ming Fang} and Wu, {Wen Jun} and Chang, {Gee Chen} and Chen, {Chin Yi} and Hu, {Suh Woan} and Tsai, {Wen Tin} and Huei Lee and Pinpin Lin",
year = "2004",
month = "4",
day = "21",
doi = "10.1016/j.toxlet.2004.01.006",
language = "English",
volume = "150",
pages = "211--219",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients

AU - Wu, Ming Fang

AU - Wu, Wen Jun

AU - Chang, Gee Chen

AU - Chen, Chin Yi

AU - Hu, Suh Woan

AU - Tsai, Wen Tin

AU - Lee, Huei

AU - Lin, Pinpin

PY - 2004/4/21

Y1 - 2004/4/21

N2 - Aryl hydrocarbon receptor (AhR)-regulated cytochrome P4501A1 (CYP1A1) and P4501B1 (CYP1B1) have been shown to metabolically activate some carcinogens. In the present study, we utilized the real-time reverse transcription-polymerase chain reaction (RT-PCR) assay to compare AhR, CYP1A1 and CYP1B1 mRNA levels in peripheral leukocytes from 42 lung cancer patients and 59 non-cancer subjects. We found that CYP1A1 and CYP1B1 levels, but not AhR, were significantly higher in patients than in non-cancer subjects. After stratified by gender, CYP1A1 levels were significantly higher in female patients than in female controls. After controlling for age, smoking status and gender, lung cancer patients were more likely to be CYP1B1 high expressers (P<0.05). Neither AhR nor CYP1A1 levels was associated with lung cancer incidence. Leu-Val polymorphism of CYP1B1 was not associated with lung cancer risk in our study. These data indicated that CYP1B1 mRNA levels were elevated in peripheral leukocytes of lung cancer patients. © 2004 Elsevier Ireland Ltd. All rights reserved.

AB - Aryl hydrocarbon receptor (AhR)-regulated cytochrome P4501A1 (CYP1A1) and P4501B1 (CYP1B1) have been shown to metabolically activate some carcinogens. In the present study, we utilized the real-time reverse transcription-polymerase chain reaction (RT-PCR) assay to compare AhR, CYP1A1 and CYP1B1 mRNA levels in peripheral leukocytes from 42 lung cancer patients and 59 non-cancer subjects. We found that CYP1A1 and CYP1B1 levels, but not AhR, were significantly higher in patients than in non-cancer subjects. After stratified by gender, CYP1A1 levels were significantly higher in female patients than in female controls. After controlling for age, smoking status and gender, lung cancer patients were more likely to be CYP1B1 high expressers (P<0.05). Neither AhR nor CYP1A1 levels was associated with lung cancer incidence. Leu-Val polymorphism of CYP1B1 was not associated with lung cancer risk in our study. These data indicated that CYP1B1 mRNA levels were elevated in peripheral leukocytes of lung cancer patients. © 2004 Elsevier Ireland Ltd. All rights reserved.

KW - Aryl hydrocarbon receptor

KW - Cytochrome P4501A1

KW - Cytochrome P4501B1

KW - Lung cancer

UR - http://www.scopus.com/inward/record.url?scp=1842839901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842839901&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2004.01.006

DO - 10.1016/j.toxlet.2004.01.006

M3 - Article

C2 - 15093676

AN - SCOPUS:1842839901

VL - 150

SP - 211

EP - 219

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 2

ER -